Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Accelerated viraemia in cats vaccinated with fixed autologous FIV-infected cells.

Karlas JA, Siebelink KH, v Peer MA, Huisman W, Rimmelzwaan GF, Osterhaus AD.

Vet Immunol Immunopathol. 1998 Oct 23;65(2-4):353-65.

PMID:
9839884
2.

Vaccination against feline immunodeficiency virus using fixed infected cells.

Verschoor EJ, van Vliet AL, Egberink HF, Hesselink W, van Alphen WE, Joosten I, Boog CJ, Horzinek MC, de Ronde A.

Vet Immunol Immunopathol. 1995 May;46(1-2):139-49.

PMID:
7618254
4.

Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infection.

Huisman W, Karlas JA, Siebelink KH, Huisman RC, de Ronde A, Francis MJ, Rimmelzwaan GF, Osterhaus AD.

Vaccine. 1998 Jan-Feb;16(2-3):181-7.

PMID:
9607028
5.

Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expression.

Boretti FS, Leutenegger CM, Mislin C, Hofmann-Lehmann R, K├Ânig S, Schroff M, Junghans C, Fehr D, Huettner SW, Habel A, Flynn JN, Aubert A, Pedersen NC, Wittig B, Lutz H.

AIDS. 2000 Aug 18;14(12):1749-57.

PMID:
10985311
6.

FIV vaccine studies. I. Immune response to recombinant FIV env gene products and outcome after challenge infection.

Lutz H, Hofmann-Lehmann R, Bauer-Pham K, Holznagel E, Tozzini F, Bendinelli M, Reubel G, Aubert A, Davis D, Cox D, et al.

Vet Immunol Immunopathol. 1995 May;46(1-2):103-13.

PMID:
7618250
7.

Targeted lymph node immunization can protect cats from a mucosal challenge with feline immunodeficiency virus.

Finerty S, Stokes CR, Gruffydd-Jones TJ, Hillman TJ, Barr FJ, Harbour DA.

Vaccine. 2001 Oct 12;20(1-2):49-58.

PMID:
11567745
8.

Recombinant FeLV vaccine: long-term protection and effect on course and outcome of FIV infection.

Hofmann-Lehmann R, Holznagel E, Aubert A, Ossent P, Reinacher M, Lutz H.

Vet Immunol Immunopathol. 1995 May;46(1-2):127-37.

PMID:
7618252
9.

Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates.

Pu R, Coleman J, Omori M, Arai M, Hohdatsu T, Huang C, Tanabe T, Yamamoto JK.

AIDS. 2001 Jul 6;15(10):1225-37.

PMID:
11426067
10.
11.

Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats.

Kusuhara H, Hohdatsu T, Okumura M, Sato K, Suzuki Y, Motokawa K, Gemma T, Watanabe R, Huang C, Arai S, Koyama H.

Vet Microbiol. 2005 Jul 1;108(3-4):155-65.

PMID:
15899558
12.

Enhancement after feline immunodeficiency virus vaccination.

Hosie MJ, Osborne R, Reid G, Neil JC, Jarrett O.

Vet Immunol Immunopathol. 1992 Dec;35(1-2):191-7.

PMID:
1337397
13.

Prime-boost vaccination using DNA and whole inactivated virus vaccines provides limited protection against virulent feline immunodeficiency virus.

Dunham SP, Bruce J, Klein D, Flynn JN, Golder MC, MacDonald S, Jarrett O, Neil JC.

Vaccine. 2006 Nov 30;24(49-50):7095-108. Epub 2006 Jul 18.

PMID:
17049683
14.

HIV-1 p24 vaccine protects cats against feline immunodeficiency virus infection.

Coleman JK, Pu R, Martin M, Sato E, Yamamoto JK.

AIDS. 2005 Sep 23;19(14):1457-66.

PMID:
16135898
15.

Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizing antibodies.

Matteucci D, Pistello M, Mazzetti P, Giannecchini S, Del Mauro D, Zaccaro L, Bandecchi P, Tozzini F, Bendinelli M.

J Virol. 1996 Jan;70(1):617-22.

16.

DNA vaccination using expression vectors carrying FIV structural genes induces immune response against feline immunodeficiency virus.

Cuisinier AM, Mallet V, Meyer A, Caldora C, Aubert A.

Vaccine. 1997 Jul;15(10):1085-94.

PMID:
9269051
17.

Effect of dual-subtype vaccine against feline immunodeficiency virus infection.

Hohdatsu T, Okada S, Motokawa K, Aizawa C, Yamamoto JK, Koyama H.

Vet Microbiol. 1997 Nov;58(2-4):155-65.

PMID:
9453127
18.

16alpha-Bromo-epiandrosterone therapy modulates experimental feline immunodeficiency virus viremia: initial enhancement leading to long-term suppression.

Pedersen NC, North TW, Rigg R, Reading C, Higgins J, Leutenegger C, Henderson GL.

Vet Immunol Immunopathol. 2003 Aug 15;94(3-4):133-48.

PMID:
12909410
19.

Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18.

Dunham SP, Flynn JN, Rigby MA, Macdonald J, Bruce J, Cannon C, Golder MC, Hanlon L, Harbour DA, Mackay NA, Spibey N, Jarrett O, Neil JC.

Vaccine. 2002 Feb 22;20(11-12):1483-96.

PMID:
11858854
20.

MHC-restricted protection of cats against FIV infection by adoptive transfer of immune cells from FIV-vaccinated donors.

Pu R, Omori M, Okada S, Rine SL, Lewis BA, Lipton E, Yamamoto JK.

Cell Immunol. 1999 Nov 25;198(1):30-43.

PMID:
10612649

Supplemental Content

Support Center